|
Hi,
The way my onc described it to me was that the spread was not that it went to the brain more or first, than other breast cancers, that we are now more likely to have erradicated the systemic disease even before it is detected and that Herceptin as it does not cross the blood brain barrier, leaves our brain the least protected. Simply the reason there are more incidences of brain mets is due to the cancer not killing us via lungs, liver, bones first. It is still a heck of a lot better than the chances before Herceptin and now with some of the new drugs that cross over there is much to be excited about.
Alice
|